Celldex Therapeutics Inc. (CLDX) Climbed 6.61% or 0.02 To Price $0.28 On Monday


Celldex Therapeutics Inc. (CLDX) climbed 6.61% or 0.02 to $0.28. It is near 1.93 million shares traded, which is 120.05% compare to the average total volume 1.61 million. The market cap of CLDX is $47.58 million. The year to date change is -83.94%. The 52 week price range is from $0.26 to $3.09. Price of CLDX have changed -13.33% during last week. It have changed -22.98% over last month, -39.81% over last 3 months, -61.07% over last 6 months and -91.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 0.36. It is 28.57% above current price. The 200-day Moving Averages for CLDX is 0.84. It is 200.00% above current price. The 52-week High is 3.09. It is 1003.57% from the current price. The 52-week Low is 0.26. It is -7.14% from current price.

There are some statistics of CLDX. It is has market cap $47.58 million. The share outstanding is 172.47 million. The average volume is 1.61 million. The percent of top 15 Institution holding is 47.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -84.41%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -60.12%.


Tags:

Share this post